BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 10638976)

  • 1. Variations in activin receptor, inhibin/activin subunit and follistatin mRNAs in human prostate tumour tissues.
    van Schaik RH; Wierikx CD; Timmerman MA; Oomen MH; van Weerden WM; van der Kwast TH; van Steenbrugge GJ; de Jong FH
    Br J Cancer; 2000 Jan; 82(1):112-7. PubMed ID: 10638976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation in pituitary expression of mRNAs encoding the putative inhibin co-receptor (betaglycan) and type-I and type-II activin receptors during the chicken ovulatory cycle.
    Lovell TM; Knight PG; Gladwell RT
    J Endocrinol; 2005 Sep; 186(3):447-55. PubMed ID: 16135664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human testicular germ cell tumours express inhibin subunits, activin receptors and follistatin mRNAs.
    van Schaik RH; Wierikx CD; Looijenga LH; Oosterhuis JW; de Jong FH
    Br J Cancer; 1997; 76(9):1191-8. PubMed ID: 9365168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of activin and inhibin subunits, receptors and binding proteins in human pheochromocytomas: a study based on mRNA analysis and immunohistochemistry.
    Hofland J; van Nederveen FH; Timmerman MA; Korpershoek E; de Herder WW; Lenders JW; Verhofstad AA; de Krijger RR; de Jong FH
    Clin Endocrinol (Oxf); 2007 Mar; 66(3):335-40. PubMed ID: 17302865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The TRPS1 transcription factor: androgenic regulation in prostate cancer and high expression in breast cancer.
    Chang GT; Jhamai M; van Weerden WM; Jenster G; Brinkmann AO
    Endocr Relat Cancer; 2004 Dec; 11(4):815-22. PubMed ID: 15613454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification of activins from androgen-independent Shionogi carcinoma cells demonstrates enhanced expression of activin betaB-subunit under androgen-depleted cell conditions in vitro and in vivo.
    Tanaka A; Hasegawa Y; Hakamata Y; Kamiakito T; Kuriki K; Yoshida H; Fukayama M
    J Cell Physiol; 2001 Aug; 188(2):194-200. PubMed ID: 11424086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activin-related proteins in bovine mammary gland: localization and differential expression during gestational development and differentiation.
    Bloise E; Cassali GD; Ferreira MC; Ciarmela P; Petraglia F; Reis FM
    J Dairy Sci; 2010 Oct; 93(10):4592-601. PubMed ID: 20854993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibin, activin, follistatin, activin receptors and beta-glycan gene expression in the villous tissue of miscarriage patients.
    Muttukrishna S; Bearfield C; Johns J; Jauniaux E
    Mol Hum Reprod; 2004 Nov; 10(11):793-8. PubMed ID: 15361555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of prostate branching morphogenesis by activin A and follistatin.
    Cancilla B; Jarred RA; Wang H; Mellor SL; Cunha GR; Risbridger GP
    Dev Biol; 2001 Sep; 237(1):145-58. PubMed ID: 11518512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of prostate-specific antigen by activin A in prostate cancer LNCaP cells.
    Fujii Y; Kawakami S; Okada Y; Kageyama Y; Kihara K
    Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E927-31. PubMed ID: 14761877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of growth and prostatic marker expression by activin A in an androgen-sensitive prostate cancer cell line LNCAP.
    Zhang Z; Zhao Y; Batres Y; Lin MF; Ying SY
    Biochem Biophys Res Commun; 1997 May; 234(2):362-5. PubMed ID: 9177276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer.
    Zheng W; Luo MP; Welt C; Lambert-Messerlian G; Sung CJ; Zhang Z; Ying SY; Schneyer AL; Lauchlan SC; Felix JC
    Gynecol Oncol; 1998 Apr; 69(1):23-31. PubMed ID: 9570994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of activin/inhibin subunit and activin receptor mRNAs in normal and neoplastic ovarian surface epithelium (OSE).
    Choi KC; Kang SK; Nathwani PS; Cheng KW; Auersperg N; Leung PC
    Mol Cell Endocrinol; 2001 Mar; 174(1-2):99-110. PubMed ID: 11306176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of inhibin/activin subunit messenger ribonucleic acids (mRNAs) by activin A and expression of activin receptor mRNAs in cultured human granulosa-luteal cells.
    Erämaa M; Hildén K; Tuuri T; Ritvos O
    Endocrinology; 1995 Oct; 136(10):4382-9. PubMed ID: 7664658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentially expressed genes in androgen-dependent and -independent prostate carcinomas.
    Chang GT; Blok LJ; Steenbeek M; Veldscholte J; van Weerden WM; van Steenbrugge GJ; Brinkmann AO
    Cancer Res; 1997 Sep; 57(18):4075-81. PubMed ID: 9307296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of an activin-follistatin growth modulatory system in the human prostate: secretion and biological activity in primary cultures of prostatic epithelial cells.
    Wang Q; Tabatabaei S; Planz B; Lin CW; Sluss PM
    J Urol; 1999 Apr; 161(4):1378-84. PubMed ID: 10081911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation.
    Di Simone N; Crowley WF; Wang QF; Sluss PM; Schneyer AL
    Endocrinology; 1996 Feb; 137(2):486-94. PubMed ID: 8593793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The activin-follistatin system in the neonatal ovine uterus.
    Hayashi K; Carpenter KD; Gray CA; Spencer TE
    Biol Reprod; 2003 Sep; 69(3):843-50. PubMed ID: 12748120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth regulation of human prostate cancer cells by bone morphogenetic protein-2.
    Ide H; Yoshida T; Matsumoto N; Aoki K; Osada Y; Sugimura T; Terada M
    Cancer Res; 1997 Nov; 57(22):5022-7. PubMed ID: 9371496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activin inhibition of prostate cancer cell growth: selective actions on androgen-responsive LNCaP cells.
    Dalkin AC; Gilrain JT; Bradshaw D; Myers CE
    Endocrinology; 1996 Dec; 137(12):5230-5. PubMed ID: 8940339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.